CliffBio
small molecule

ISOSORBIDE MONONITRATE

ISOSORBIDE MONONITRATE

Loss of exclusivity—loss of exclusivity
CompanyGenus Lifesciences Inc. →See this company's full patent-cliff portfolio

Drug detail

Brand nameISOSORBIDE MONONITRATE
Active ingredientISOSORBIDE MONONITRATE
Strength20MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1998
Marketing statusRX

More from Genus Lifesciences Inc.

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ISOSORBIDE MONONITRATE patent cliff — loss of exclusivity — | CliffBio